KIMBERLY BARNES: Open Payments
NPI 1649634577 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 80 payments from 18 companies in 2025. Trend: 2023 $2,066 · 2024 $1,834 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $253 |
| PFIZER INC. | 10 | $163 |
| ABBVIE INC. | 11 | $150 |
| Lilly USA, LLC | 9 | $134 |
| Astellas Pharma US Inc | 7 | $120 |
| SANOFI-AVENTIS U.S. LLC | 4 | $93 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Novo Nordisk Inc | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
Products named: JARDIANCE, NURTEC ODT, Veozah, TZIELD, UBRELVY, Ozempic, Kerendia, FARXIGA.
Industry payments across TX — which companies pay providers there.
